Skip to content

Headache & Migraine

Frontiers in Neurology · Ou et al. · 2020 · 2,874 participants

A Systematic Review and Meta-analysis of the Therapeutic Effect of Acupuncture on Migraine

Strong
  • Acupuncture Group1,396 participants
  • Medication Group865 participants
  • MD=1.88

    Efficacy vs sham acupuncture

  • MD=1.16

    Efficacy vs medication

  • MD=-0.59

    VAS scale reduction vs sham

Study design sheet

  • n=2874 participants
  • High Clinical Impact
Design
Systematic Review and Meta-analysis
Participants
2,874

n = 2,874; median of studies with the same design: 1,449

Duration

1-2 months of treatment

1- to 2-month treatments with follow-up of up to 6 months

Groups
  • Acupuncture Group (1,396)Traditional acupuncture or electroacupuncture
  • Medication Group (865)Flunarizine, ergotamine, or other medications
  • Sham Acupuncture Group (613)Acupuncture at non-specific points
OBJECTIVE
Investigate the efficacy and safety of acupuncture for migraine compared with medications and sham acupuncture
WHO
2,874 patients diagnosed with migraine from 28 randomized controlled trials
POINTS
Points on the Shaoyang meridians, including traditional acupuncture and electroacupuncture
Results in numbers
  • MD=1.88Efficacy vs sham acupuncture
  • MD=1.16Efficacy vs medication
  • MD=-0.59VAS scale reduction vs sham
  • RR=0.16Adverse events rate

What does this mean for you?

This large study shows that acupuncture was more effective than sham acupuncture at reducing the frequency of migraine attacks and pain. Compared with medications, the authors observed a higher response rate and fewer adverse reactions with acupuncture, but no significant difference in pain (VAS scale) or attack duration, and with substantial heterogeneity among studies; they therefore call for larger studies to confirm these results.

Article summary

Plain-language narrative summary

**Acupuncture as a Treatment for Migraine: A Comprehensive Analysis of 28 Clinical Trials**

Migraine is one of the most challenging and impactful neurological conditions of our time, affecting millions of people around the world. Characterized by intense, throbbing headaches, often accompanied by nausea, vomiting, and excessive sensitivity to light and sound, migraine can be extremely debilitating. The Global Burden of Disease Study 2016 ranked migraine as the sixth most disabling disease globally, evidencing its enormous impact for both individuals and society. The conventional treatments available, although they may provide relief, are frequently associated with significant side effects and may not be able to fully prevent attacks, especially when used over long periods.

This scenario has led researchers and healthcare professionals to investigate alternative and complementary therapies, with acupuncture being one of the most promising options due to its demonstrated efficacy in clinical studies and its favorable safety profile.

This study represents a comprehensive systematic review and meta-analysis that examined 28 randomized controlled trials to assess the efficacy and safety of acupuncture in the treatment of migraine. The researchers conducted extensive searches in eight major medical databases, including PubMed, Cochrane Library, Embase, and specialized Chinese databases, covering publications from January 2000 to March 2019. To ensure the quality of the research, only studies that followed rigorous criteria were included: patients with a clear diagnosis of migraine, treatment groups that received exclusively acupuncture, control groups that used sham acupuncture or conventional medications, and standardized assessments of outcomes using measures such as attack frequency, duration, pain intensity through the visual analog scale, and cerebral blood flow examinations. The final analysis included 2,874 patients distributed in three groups: 1,396 received real acupuncture, 865 used conventional medications, and 613 received sham acupuncture.

The results of this research were consistently favorable to acupuncture in multiple aspects. When compared with sham acupuncture, true acupuncture demonstrated statistically significant superiority in virtually all evaluated measures. Patients who received real acupuncture experienced an average reduction of 1.00 point in the monthly frequency of migraine attacks, an improvement that may seem modest numerically but represents substantial relief for those suffering from this condition. Pain intensity, measured by the visual analog scale where zero represents absence of pain and ten represents unbearable pain, showed an average reduction of 0.59 points in the acupuncture group compared with the group that received sham acupuncture.

In addition, the overall efficacy rate of treatment was significantly superior, with more patients experiencing clinically relevant improvement. In the comparison with conventional medications, the authors report a higher therapeutic efficacy rate and fewer adverse reactions with acupuncture (2 of 159 patients, versus 18 of 158, or 11.39%, in the medication group; RR=0.16). However, there was no significant difference in VAS improvement (MD=-0.46; P=0.07) or in attack duration (MD=-0.58; P=0.08), and the comparisons with medications showed high heterogeneity, as the authors themselves point out.

A complementary analysis assessed cerebral blood flow by transcranial Doppler (TCD), in five studies with 457 patients whose control group received medication. Migraine is frequently associated with alterations in cerebral circulation, and the authors report that flow velocity in the anterior, middle, and posterior cerebral arteries decreased more with acupuncture than with medication (P=0.05 for the posterior cerebral artery). However, heterogeneity among the studies was high (I2 of 65% to 92%), which, according to the authors themselves, makes the result unreliable. The mechanism by which acupuncture would act on intracranial hemodynamics is not clear, so this finding should be seen as a hypothesis to be verified.

The clinical implications of these findings are substantial for both patients and healthcare professionals. For patients, especially those suffering from side effects of conventional medications or who present an inadequate response to traditional treatments, acupuncture emerges as a viable and effective therapeutic option. The very low incidence of adverse effects makes acupuncture particularly attractive for long-term preventive use, a crucial consideration given that migraine is frequently a chronic condition that requires ongoing management. For healthcare professionals, these results suggest that acupuncture should be considered as an integral part of a multidisciplinary approach to migraine treatment, whether as primary or complementary therapy.

Because the cerebral circulation data are heterogeneous, they do not allow conclusions about preventive benefits or about modification of the underlying pathophysiological processes.

However, it is essential to recognize the important limitations of this analysis. Heterogeneity among studies was considerable, reflecting differences in the acupuncture protocols used, in the selection of specific points, in treatment duration, and in evaluation criteria. Most of the included studies had relatively small sample sizes, and few were conducted as multicenter studies, which may limit the generalization of the results. In addition, the nature of acupuncture makes it extremely difficult to conduct true double-blind studies, since the acupuncturist necessarily knows the type of treatment being administered.

Funnel plot analysis suggested the possible existence of publication bias, indicating that studies with negative results may have been less likely to be published. Despite these methodological limitations, the consistency of the favorable results for acupuncture across multiple outcomes and the magnitude of the effects observed strengthen the credibility of the conclusions.

This research represents a significant contribution to the evidence base on acupuncture in the treatment of migraine, convincingly demonstrating that this ancient therapy has measurable clinical efficacy and a favorable safety profile. The results support the use of acupuncture as a legitimate therapeutic option for patients with migraine, offering an alternative or complement to conventional pharmacological treatments. For future developments in the area, the researchers emphasize the need for prospective multicenter studies with larger samples and more standardized protocols, which could provide even more robust evidence and guide the development of more specific clinical guidelines for the use of acupuncture in migraine management.

Strengths

  • Large sample with 2,874 patients from 28 studies
  • Comparison with active controls (medications) and placebo
  • Assessment of multiple outcomes including safety
  • Exploratory analysis of hemodynamic changes by transcranial Doppler (result with high heterogeneity)
  • Rigorous methodology following Cochrane guidelines

Limitations

  • Significant heterogeneity among some studies
  • Most studies with small samples (40-60 patients)
  • Few multicenter studies included
  • Difficulty of adequate blinding in acupuncture studies
  • Variation in acupuncture protocols among studies

Historical Context

The 3 events to scale, from 2000 to 2020: the distance between dots is proportional to time. In blue, this study. The longest gap runs from 2009 to 2020 (11 years).
  1. 2000Data inicial da busca desta meta-análise para artigos publicados em idiomas que não o chinês
  2. 2009Data inicial da busca desta meta-análise para relatos publicados em chinês
  3. 2020Esta meta-análise: acupuntura superior à simulada; resultados frente a medicamentos limitados pela heterogeneidade
Dr. Marcus Yu Bin Pai

Expert Commentary

Clinical Relevance

Migraine represents one of the most frequent diagnoses in pain outpatient clinics, and the practical question that arises daily is how to optimize prophylaxis without overburdening the patient with adverse effects of medications such as flunarizine or ergotamine. This meta-analysis of 28 randomized controlled trials with 2,874 patients responds directly to this dilemma: acupuncture surpassed sham acupuncture and showed a higher efficacy rate and fewer adverse reactions than conventional drugs (RR=0.16 versus the medication group), although with no significant difference in VAS or attack duration and with high heterogeneity in the comparisons with drugs, as the authors stress. This suggests acupuncture as an alternative to consider for patients who do not tolerate pharmacological prophylaxis, for pregnant women with chronic migraine in whom the medication arsenal is restricted, and for those with a history of complex drug interactions. Transcranial Doppler suggested a greater reduction in flow velocity in the anterior, middle, and posterior cerebral arteries with acupuncture than with drugs, but the heterogeneity (I2 of 65% to 92%) makes this result unreliable and does not allow us to state that the therapeutic effect goes beyond symptom control.

Notable Findings

The finding that deserves special attention is that the difference in efficacy versus sham acupuncture (MD=1.88) is greater than the difference versus medication (MD=1.16), suggesting that the specificity of the needled points has real weight in the outcome and that true acupuncture surpasses even the effect of the therapeutic context. The reduction of 0.59 points on the VAS scale versus the sham group, although numerically modest, translates into a concrete functional difference for those living with recurrent attacks. The hemodynamic analysis is exploratory: transcranial Doppler showed a greater reduction in flow velocity in the three cerebral arteries assessed with acupuncture than with drugs, but with high heterogeneity, and the authors consider the result unreliable. If confirmed, it could relate to what we know about migraine pathophysiology, namely the dysfunction of the trigeminovascular system and the oscillations of vasoconstriction and vasodilation that precede and accompany attacks; for now, the datum only brings the discussion of mechanism of action closer to the vocabulary of contemporary neurology and physiatry.

From My Experience

In my practice in the pain outpatient clinic, I usually see the first responses to acupuncture in migraine around the third or fourth session — reduction in attack intensity or in rescue analgesic consumption. For stabilization of monthly frequency, generally between eight and twelve sessions are necessary in the initial cycle, with monthly maintenance afterward. The profile that responds best, in my experience, is the patient with high-frequency episodic migraine who already presents the phenomenon of analgesic medication overuse: removing the abuse cycle and introducing acupuncture simultaneously has generated consistent results. I routinely associate biofeedback and sleep hygiene guidance, and in patients with associated cervicogenic component I include dry needling of suboccipital muscle trigger points. I do not indicate acupuncture as monotherapy in migraine with frequent aura and uncontrolled cardiovascular risk factors, where investigation and supervised pharmacological prophylaxis take priority. The hemodynamic Doppler findings in this work are consistent with what I have observed clinically in patients who report less sensation of intracranial heaviness and pulsation after the complete cycle.

Dr. Marcus Yu Bin Pai · MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

Frontiers in Neurology · 2020

DOI: 10.3389/fneur.2020.00596

Access original article

Scientific review

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.

  • Strong
  • Moderate
  • Limited
  • Weak
19801990200020102020
This study among the Library’s studiesEach dot is a study: left to right, the publication year; top to bottom, the study design, from meta-analyses to preclinical work; colour and shape give the level of evidence. Highlighted: the Headache & Migraine studies.
See the numbers: This study among the Library’s studies
Study designHeadache & MigraineAll studies
Meta-analysis · Systematic Review23387
RCT15224
Clinical Guideline05
Observational338
Case Series07
Narrative Review7155
Preclinical / Animal06
Other11203
See the Headache & Migraine studies in the Library

Related articles

Based on this article’s categories

  1. Linde et al. · Cochrane Database of Systematic Reviews · 2009

    • Systematic Reviews & Meta-Analyses
    • Headache & Migraine
  2. Linde et al. · Cochrane Database of Systematic Reviews · 2016

    • Headache & Migraine
    • Systematic Reviews & Meta-Analyses
  3. Li et al. · Pain Research and Management · 2020

    • Headache & Migraine
    • Systematic Reviews & Meta-Analyses
  4. Liu et al. · Journal of Pain Research · 2024

    • Headache & Migraine
    • Systematic Reviews & Meta-Analyses